RORC and chronic obstructive pulmonary disease: Although there are some reports correlating the pharmacological regulation of Th17 dependent cytokines and their implication in COPD, this is the first report of an RORγ inhibitor as a potential therapeutic agent for COPD as depicted in the Fig. 535–39.